TB

This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 3HR regimen.

Speakers for this webinar include the Deputy Director of the Global TB Institute and a survivor of MDR-TB. By the end of the webinar, participants will be able to: define stigma in the context of tuberculosis prevention and care, describe how stigma affects persons with tuberculosis, and apply interventions in the health care setting and community to reduce stigma.

The website includes various resources that were developed to address the difficulties that HIV programs might encounter when implementing TB preventive treatment. Programs can adapt the tools as needed.

The handbook provides information on safety issues involved in the processing and management of samples potentially containing Mycobacterium tuberculosis. Topics covered in the handbook include safe working practices, laboratory infrastructure and layout, personal protective equipment, and more.

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

This wepage provides information on the similarities between COVID-19 and tuberculosis, wearing a mask, reducing stigma, and more. The document is also available in English, French, Spanish, Russian, Polish, and Chinese.

This document lists competencies in the areas of knowledge, judgement, skills, and attitudes important for TB Screening.

This training manual was created to build and strengthen the capacity of people with and affected by TB to better understand the human rights issues and abuses they encounter and be able to respond constructively by building on previous experience in participating in a TB-or and human rights-related activity.

This tool provides a daily Rifampin Schedule for Latent Tuberculosis (TB) patients.

The target audience for this webinar is physicians and other healthcare workers who may diagnose and treat coccidioidomycosis (Valley Fever) and/or tuberculosis. Topics covered include coinfection, the difference between tuberculosis and Valley Fever, and more.